This accredited online course provides a comprehensive overview of the intersecting vulnerabilities and strategies for HIV and mental health management.

Accreditation: USask CPE accredited for 1.0 CEUs

Target Audience: pharmacists, technicians, and allied healthcare professionals

Registration: Free for Saskatchewan Pharmacy Professionals. Out of province, $40.00.

• Register SK
• Register Canada-Wide

Learning Objectives

At the end of the course, participants will be able to:

1. Understand HIV rates globally, nationally, and locally.
2. Expand understanding of HIV treatment and monitoring.
3. Discuss how mental health conditions and HIV intersect and affect individuals living with both.
4. Review testing and prevention of HIV transmission with a focus on people living with mental health conditions .
5. Review specific drug interactions and side-effects relating to HIV and psychotropic medications

This accredited online course provides a comprehensive overview of maternal/paternal and perinatal HIV management.

Accreditation: USask CPE accredited for 1.0 CEUs

Target Audience: pharmacists, technicians, and allied healthcare professionals

Registration: Free for Saskatchewan Pharmacy Professionals. Out of province, $40.00.

• Register SK
• Register Canada-Wide

Learning Objectives

At the end of the course, participants will be able to:

1. Describe current rates of HIV transmission in Saskatchewan with a focus on heterosexual transmission and transmission rates among women.
2. Understand transmission of HIV in Saskatchewan with a focus on vertical transmission.
3. Understand the use of PrEP in people who are pregnant or may become pregnant, and have an increased risk of acquiring HIV.
4. Describe treatment for people living with HIV in Saskatchewan, specifically during pregnancy.
5. Understand prevention of vertical HIV transmission in high, intermediate, and low risk of transmission.
6. Review the newest breastfeeding guidelines.

This is an online course
Accreditation:

• HIV 101 is USask CPE accredited for 3.5 hours (CEUs)
• HIV Treatment is USask CPE accredited for 2.5 hours (CEUs)

Target Audience: Saskatchewan healthcare and allied professionals 

Registration Fee: Free!

• Register
• More Information

• Register SK
• Register Canada-Wide
• More Information

Course Information

This online course is mandatory for licensed pharmacy professionals in Saskatchewan. 

Accreditation: Harm Reduction Primer and OAT Standards is USask CPE accredited for 2.5 CEUs

Target Audience: Saskatchewan pharmacy professionals

Registration: $45.00 + GST

Learning Objectives

At the end of the course, participants will be able to:

1. Be familiar with opioid agonist therapies available in Saskatchewan.
2. Describe differences between traditional and micro-dosing buprenorphine/
   naloxone induction.
3. Define trauma-informed-care and identify strategies used to support culturally
   safe pharmacy practice.
4. Recognize standard requirements for dispensing opioid agonist therapy (OAT) in Saskatchewan.
5. Identify valid prescriptions for opioid agonist therapy (OAT) in Saskatchewan.

• Register

This course includes an online course and a recorded, virtual workshop. Completion of the Online Course fulfills SCPP requirements. Registrants are not required to complete the virtual workshop.

Note: The virtual workshop is a recorded version of the live course that was held on March 20, 2021 

Accreditation (USask CPE):

• Workshop: 7.50 CEUs
• Online Course: 6 CEUs

• Register
• Course Information and Learning Objectives

This course includes an online course and a recorded, virtual workshop. Completion of the Online Course fulfills SCPP requirements. Registrants are not required to complete the virtual workshop.

Note: Upon completion, you will print a statement of completion and meet the requirements to sell exempted codeine products.

Accreditation (USask CPE): This course is accredited for 2.0 CEUs

Registration Fee: $35.00 + GST

Learning Objectives:

Following completion of this training, pharmacists will be able to:

• Utilize the developed tools when a patient requests an exempted codeine product.
• Apply evidence to assess potential benefit of an exempted codeine product to a patient request.
• Evaluate the risk of providing an exempted codeine product to a patient.
• Communicate the benefit and risk of exempted codeine products to patients.
• Complete the documentation required for exempted codeine sales.

• Register